CME Group IncCME
Price$265.10Intrinsic value$264.150% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $6.8B+10.5% YoYTTM through 30 Jun 2026
Net Income $4.3B+21.6% YoYTTM through 30 Jun 2026
Free Cash Flow $4.2BTTM through 30 Jun 2026

Margins

Current
Operating Margin65.1%
Net Margin63.3%

Returns

16.2%ROE
2.2%ROA

Balance Sheet Health

Current Ratio1.02x
Cash & Equivalents$2.1B

Quality Metrics

Altman Z-Score0.51
Piotroski F-Score6 / 9
FCF Margin62.2%
Rule of 4066.1
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $6.5B
Diluted EPS$11.79TTM
'19'20'21'22'23'24'25
FY2025: $11.16

Dividend

$4.75Per share, FY20261.78%Yield+6.9%5-yr growth

Capital Allocation

Capex Intensity1.4%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.